These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6413361)

  • 1. Clinical uses of synthetic growth hormone.
    Hintz RL; Rosenfeld RG
    Hosp Pract (Off Ed); 1983 Oct; 18(10):115-9, 123-4. PubMed ID: 6413361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of growth hormone treatment in girls with Turner syndrome].
    Rongen-Westerlaken C
    Tijdschr Kindergeneeskd; 1988 May; 56 Suppl 1():31-2. PubMed ID: 3413772
    [No Abstract]   [Full Text] [Related]  

  • 3. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
    Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J
    J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Turner syndrome with growth hormone.
    Van Vliet G; Collu R
    J Pediatr; 1993 Apr; 122(4):671-2. PubMed ID: 8463926
    [No Abstract]   [Full Text] [Related]  

  • 5. Knemometry as a predictor of response to somatrem in Turner's syndrome.
    Wales JK; Milner RD
    Acta Paediatr Scand Suppl; 1987; 337():37-9. PubMed ID: 3481183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome.
    Rosenfeld RG; Hintz RL; Johanson AJ; Sherman B; Brasel JA; Burstein S; Chernausek S; Compton P; Frane J; Gotlin RW
    J Pediatr; 1988 Aug; 113(2):393-400. PubMed ID: 3397807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group.
    Rongen-Westerlaken C; Wit JM; De Muinck Keizer-Schrama SM; Otten BJ; Oostdijk W; Delemarre-van der Waal HA; Gons MH; Bot A; Van den Brande JL
    Eur J Pediatr; 1992 Jul; 151(7):477-81. PubMed ID: 1396905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year results of treatment with methionyl human growth hormone in children with Turner syndrome. Dutch Growth Hormone Working Group.
    Rongen-Westerlaken C; Fokker MH; Wit JM; De Muinck Keizer-Schrama SM; Otten BJ; Oostdijk W; Delemarre van den waal HA; Gons MH; Bot A
    Acta Paediatr Scand; 1990; 79(6-7):658-63. PubMed ID: 2386058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionyl human growth hormone in Turner's syndrome.
    Rongen-Westerlaken C; Wit JM; Drop SL; Otten BJ; Oostdijk W; Waal HA; Gons MH; Bot A; Van den Brande JL
    Arch Dis Child; 1988 Oct; 63(10):1211-7. PubMed ID: 3196048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of final body heights in patients treated with growth hormone (somatotropin deficiency and Turner syndrome)].
    Rochiccioli P; Tauber MT
    Arch Pediatr; 1996; 3 Suppl 1():154s-155s. PubMed ID: 8795999
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Turner's syndrome with methionyl human growth hormone for six months.
    Takano K; Hizuka N; Shizume K
    Acta Endocrinol (Copenh); 1986 May; 112(1):130-7. PubMed ID: 3521183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic methionyl human growth hormones is biologically active in adult man.
    Hintz RL; Rosenfeld RG; Wilson DM; Bennett A; Finno J; McClellan B; Swift R
    Lancet; 1982 Jun; 1(8284):1276-9. PubMed ID: 6123021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of 46 patients with Turner's syndrome with recombinant human growth hormone (YM-17798) for three years: a multicentre study.
    Takano K; Shizume K; Hibi I
    Acta Endocrinol (Copenh); 1992 Apr; 126(4):296-302. PubMed ID: 1595324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of growth in Turner syndrome patients treated with growth hormone: summary of three-year results.
    Rosenfeld RG
    J Endocrinol Invest; 1989; 12(8 Suppl 3):49-51. PubMed ID: 2681348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wider indications for treatment with biosynthetic human growth hormone in children.
    Hindmarsh PC; Bridges NA; Brook CG
    Clin Endocrinol (Oxf); 1991 May; 34(5):417-27. PubMed ID: 2060152
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone in Turner syndrome.
    Price DA; Ranke MB
    Arch Dis Child; 2001 Jun; 84(6):525. PubMed ID: 11372087
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Turner syndrome].
    Ferrández A; Mayayo E; Sanjuan P; Bello E; Labarta JI
    An Esp Pediatr; 1992 Jun; 36 Suppl 50():105-8. PubMed ID: 1416500
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities to increase the efficacy of growth hormone therapy in Turner syndrome].
    Ságodi L; Sólyom E
    Orv Hetil; 1997 Jun; 138(23):1501-5. PubMed ID: 9254366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genentech agrees to drop promotion of growth hormone.
    Macilwain C
    Nature; 1994 Oct; 371(6498):550. PubMed ID: 7935778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.